SLAMF8 Antikörper
Kurzübersicht für SLAMF8 Antikörper (ABIN604455)
Target
Alle SLAMF8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Recognizes human BLAME.
-
Aufreinigung
- Protein G purified
-
Sterilität
- 0.2 μm filtered
-
Immunogen
- Purified, NS0-derived, recombinant human B Lymphocyte Activator Macrophage-Expressed (a 23-233, Accession #Q9P0V8).
-
Isotyp
- IgG2a
-
-
-
-
Applikationshinweise
-
Approved: ELISA (2 - 8 μg/mL)
Usage: Suitable for use in ELISA:2-8 μg/mL. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Sterile PBS
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from a 0.2 um filtered solution in PBS, 5 % trehalose
-
Handhabung
- Aliquot to Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Lyophilized powder may be stored at -20°C. Stable for 1 year at -20°C. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Reconstituted product is stable for 1 year at -20°C.
-
-
- SLAMF8 (SLAM Family Member 8 (SLAMF8))
-
Andere Bezeichnung
- SLAMF8
-
Hintergrund
-
Name/Gene ID: SLAMF8
Synonyms: SLAMF8, BCM-like membrane protein, CD353, CD353 antigen, SBBI42, SLAM family member 8, BLAME -
Gen-ID
- 56833
-
UniProt
- Q9P0V8
Target
-